| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Powder pattern and hydrogen bonding in the crystal structure of phenelzine sulfate, C
	      8
	    H
	      14
	    N
	      2
	    (SO
	      4
	    ). Powder Diffraction , 1-5. 10.1017/s0885715625000545. | BXDS-WLE | Peer-Reviewed Article | Health | 
		
		    
    | Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of niraparib tosylate monohydrate Form I, (C
	      19
	    H
	      21
	    N
	      4
	    O)(C
	      7
	    H
	      7
	    O
	      3
	    S)(H
	      2
	    O). Powder Diffraction , 1-9. 10.1017/s0885715625000181. | BXDS-WLE | Peer-Reviewed Article | Health | 
		
		    
    | Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of ethynodiol diacetate, C
	      24
	    H
	      32
	    O
	      4
	    . Powder Diffraction , 1-6. 10.1017/s0885715625100729. | BXDS-WLE | Peer-Reviewed Article | Health | 
		
		    
    | Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of trametinib dimethyl sulfoxide, C26H23FIN5O4(C2H6OS). Powder Diffraction 40(2) , 162-167. 10.1017/s0885715625000168. | BXDS-WLE | Peer-Reviewed Article | Health | 
		
		    
    | Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of aprocitentan Form A, C16H14Br2N6O4S. Powder Diffraction 40(2) , 168-174. 10.1017/s088571562500017x. | BXDS-WLE | Peer-Reviewed Article | Health | 
		
		    
    | Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of repotrectinib, C18H18FN5O2. Powder Diffraction , 1-6. 10.1017/s0885715625100882. | BXDS-WLE | Peer-Reviewed Article | Health | 
		
		    
    | Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of palovarotene, C
	      27
	    H
	      30
	    N
	      2
	    O
	      2
	    . Powder Diffraction , 1-6. 10.1017/s0885715625100869. | BXDS-WLE | Peer-Reviewed Article | Health | 
		
		    
    | Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of givinostat hydrochloride monohydrate Form I, C
	      24
	    H
	      28
	    N
	      3
	    O
	      4
	    Cl(H
	      2
	    O). Powder Diffraction , 1-6. 10.1017/s0885715625100559. | BXDS-WLE | Peer-Reviewed Article | Health | 
		
		    
    | Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). A proposed crystal structure of fruquintinib Form I, C21H19N3O5. Powder Diffraction , 1-7. 10.1017/s0885715625100808. | BXDS-WLE | Peer-Reviewed Article | Health | 
		
		    
    | Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of iprodione, C13H13Cl2N3O3. Powder Diffraction , 1-5. 10.1017/s0885715625100742. | BXDS-WLE | Peer-Reviewed Article | Health | 
		
		    
    | Jean-Philippe Julien; Taylor Sicard; Anthony Semesi; Bebhinn Treanor; Tiantian Zhao et al. (2025). Nanoparticle platform for antibody and vaccine delivery. Patent Number: US20250114475A1. | CMCF-ID | Patent | Health | 
		
		    
    | Holyoak, T.; Tran, N. (2025). Staphylococcus aureus exfoliative toxin A D164E variant. Protein Data Bank: 9bsm. | CMCF-BM | PDB Deposition | Health | 
		
		    
    | Holyoak, T.; Tran, N. (2025). Staphylococcus aureus exfoliative toxin A D164A variant. Protein Data Bank: 9bsh. | CMCF-BM | PDB Deposition | Health | 
		
		    
    | Goncalves, Monica M.; Uday, Adwaith B.; Forrester, Taylor J. B.; Currie, S. Quinn W.; Kim, Angelina S. et al. (2025). Mechanism of allosteric activation in human mitochondrial ClpP protease. Proceedings of the National Academy of Sciences of the United States of America 122(16) . 10.1073/pnas.2419881122. [PDB: 9dqk, 9dql] | CMCF-ID | Peer-Reviewed Article | Health | 
		
		    
    | Frigon, L.; Pascal, J.M. (2025). PARP4 BRCT domain F39A mutant. Protein Data Bank: 9dfr. | CMCF-BM | PDB Deposition | Health |